Concepedia

Author

Jiansong Ji

Wenzhou Medical UniversityORCID

Also Known As

Jialu Lang, Jian-Song Ji, Jian-song Ji, JianSong Ji, Jiansong Ji, Jian‐Song Ji, Weizhong Zhou, Yongzhong Du

146

Publications

3.7K

Citations

31

H-Index

44

Concepts

All Affiliations

Wenzhou Medical UniversityLishui Central HospitalZhejiang UniversityLishui UniversityNanjing Medical University
JJ

About

Jiansong Ji is an author at Wenzhou Medical University specializing in medicine, oncology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

11

12

717

2

Cell Biology

4

4

309

3

Engineering

2

2

49

4

Health Sciences

2

2

32

5

Biomedical Engineering

2

2

49

Jiansong Ji

×

56

Publications

2.6K

Citations

28

H-Index

YearCitations

Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)

Hai‐Dong Zhu, Hai-Liang Li, Mingsheng Huang,

Signal Transduction and Targeted Therapy

2023

262

Single-cell transcriptome analysis reveals tumor immune microenvironment heterogenicity and granulocytes enrichment in colorectal cancer liver metastases

Yunbin Zhang, Jingjing Song, Zhongwei Zhao,

Cancer Letters

2019

239

Conventional stents versus stents loaded with 125iodine seeds for the treatment of unresectable oesophageal cancer: a multicentre, randomised phase 3 trial

Hai‐Dong Zhu, Jin‐He Guo, Aiwu Mao,

The Lancet Oncology

2014

151

Regulatory T cells, especially ICOS+ FOXP3+ regulatory T cells, are increased in the hepatocellular carcinoma microenvironment and predict reduced survival

Jianfei Tu, Yahui Ding, Xihui Ying,

Scientific Reports

2016

133

Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE

Chunli Kong, Zhongwei Zhao, Weiyue Chen,

European Radiology

2021

129

Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study

Zhi‐Cheng Jin, Jian-Jia Chen, Xiaoli Zhu,

EClinicalMedicine

2024

119

Curcumin analog WZ35 induced cell death via ROS-dependent ER stress and G2/M cell cycle arrest in human prostate cancer cells

Xiuhua Zhang, Minxiao Chen, Peng Zou,

BMC Cancer

2015

83

Efficacy and Safety of TACE Combined With Sorafenib Plus Immune Checkpoint Inhibitors for the Treatment of Intermediate and Advanced TACE-Refractory Hepatocellular Carcinoma: A Retrospective Study

Liyun Zheng, Shiji Fang, Fazong Wu,

Frontiers in Molecular Biosciences

2021

83

Global microarray profiling identified <i>hsa_circ_0064428</i> as a potential immune-associated prognosis biomarker for hepatocellular carcinoma

Qiaoyou Weng, Minjiang Chen, Maoquan Li,

Journal of Medical Genetics

2018

72

Sophoridine suppresses lenvatinib‐resistant hepatocellular carcinoma growth by inhibiting RAS/MEK/ERK axis via decreasing VEGFR2 expression

Zhongwei Zhao, Dengke Zhang, Fazong Wu,

Journal of Cellular and Molecular Medicine

2020

68

Page 1